The agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
View original article
Contributor: Sabrina Malhi
The agency updated its guidance in response to limited supply of an antibody drug designed to protect infants from the potentially fatal respiratory disease.
View original article
Contributor: Sabrina Malhi